Daliresp Prices, Coupons, Copay Cards & Patient Assistance
Daliresp (roflumilast) is a member of the selective phosphodiesterase-4 inhibitors drug class and is commonly used for COPD, and COPD - Maintenance.
The cost for Daliresp 250 mcg oral tablet is around $335 for a supply of 20 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
A generic version of Daliresp has been approved by the FDA. However, we either do not have pricing information for it, or it is not commercially available. View generic Daliresp availability for more details.
Daliresp prices
Oral Tablet
250 mcg
Daliresp oral tablet
from $335.26
for 20 tablets
Quantity | Per unit | Price |
---|---|---|
20 (2 x 10 each) | $16.76 | $335.26 |
28 | $16.62 | $465.46 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
500 mcg
Daliresp oral tablet
from $498.00
for 30 tablets
Quantity | Per unit | Price |
---|---|---|
30 | $16.60 | $498.00 |
90 | $16.38 | $1,474.01 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Daliresp Coupons, Copay Cards and Rebates
Daliresp offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Daliresp $25 Savings Program
Eligible commercially insured patients may pay $25 per 30-day supply; offer is good for 12 uses.
- Applies to:
- Daliresp
- Number of uses:
- 12 times
Form more information phone: 866-459-2015 or Visit website
Daliresp $25 Savings Program
Eligible cash-paying patients may save up to $100 per 30-day supply; offer is good for 12 uses; for additional information contact the program at 866-459-2015.
- Applies to:
- Daliresp
- Number of uses:
- 12 times
Form more information phone: 866-459-2015 or Visit website
Patient Assistance & Copay Programs for Daliresp
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Rx Outreach Medications
Eligibility requirements:- May have insurance
- Determined case by case
- Not required
- The patient must also be residing in the US.
- Some medications are available for a fee of $20 for up to a 180 day supply. Check the Rx Outreach website for the exact price and most current medication list. Contact Program for Spanish Application(s)/Form(s).
- Daliresp (roflumilast) Tablet
More information please phone: 314-222-0472 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Daliresp (roflumilast)
- Check interactions
- Compare alternatives
- Reviews (63)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: selective phosphodiesterase-4 inhibitors
- Breastfeeding
- En español